Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

GenMont Biotech, Inc. (3164) Income Statement

GenMont Biotech, Inc. Income Statement

Last quarter (Q2 2026), GenMont Biotech, Inc.'s total revenue was NT$103.33M, a decrease of 7.88% from the same quarter last year. In Q2, GenMont Biotech, Inc.'s net income was NT$15.54M. See GenMont Biotech, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 401.23MNT$ 385.37MNT$ 318.01MNT$ 368.55MNT$ 427.93M
NT$ 251.63MNT$ 238.18MNT$ 211.19MNT$ 256.72MNT$ 299.33M
NT$ 193.88MNT$ 198.06MNT$ 204.20MNT$ 194.75MNT$ 170.99M
Depreciation and AmortizationNT$ 66.95MNT$ 71.59MNT$ 64.78MNT$ 50.41MNT$ 21.13M
NT$ 124.57MNT$ 140.03MNT$ 93.92MNT$ 117.43MNT$ 161.29M
NT$ 57.75MNT$ 40.12MNT$ 6.99MNT$ 60.18MNT$ 143.49M
NT$ 5.93MNT$ 24.08MNT$ 21.18MNT$ 6.08MNT$ -4.06M
NT$ 63.68MNT$ 64.72MNT$ 28.16MNT$ 66.26MNT$ 139.42M
NT$ 57.20MNT$ 57.25MNT$ 32.99MNT$ 56.98MNT$ 113.13M
Per Share Metrics
Basic EPSNT$ 0.66NT$ 0.66NT$ 0.38NT$ 0.66NT$ 1.31
Diluted EPSNT$ 0.66NT$ 0.66NT$ 0.38NT$ 0.66NT$ 1.30
Weighted Average Shares Outstanding72.70M86.51M86.57M86.37M86.36M
Weighted Average Shares Outstanding (Diluted)72.70M86.73M86.57M86.66M86.74M

Currency in TWD

GenMont Biotech, Inc. Earnings and Revenue History

0150M300M450M0 %15 %30 %45 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin